Truly personalized therapy — an end to the era of one size fits all

Truly personalized therapy — an end to the era of one size fits allTruly personalized therapy — an end to the era of one size fits all, Published online: 15 January 2019; doi:10.1038/s41571-018-0165-1In 2018, several trials in breast cancer have shown efficacy of strategies that rely on novel markers, including gene expression assays or pathological complete response. The relevance of targeted strategies in patient subgroups and of immunotherapy efficacy were demonstrated.
Source: Nature Clinical Practice Oncology - Category: Cancer & Oncology Authors: Source Type: research